Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-06T08:06:22.505Z Has data issue: false hasContentIssue false
  • English
  • Français

Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex

Published online by Cambridge University Press:  08 April 2016

Massimo Colaneri ,
Andrea Quarti  and
Marco Pozzi
Massimo Colaneri*
Affiliation:
Department of Paediatric and Congenital Cardiac Surgery and Cardiology, Ospedali Riuniti, Ancona, Italy
Andrea Quarti
Affiliation:
Department of Paediatric and Congenital Cardiac Surgery and Cardiology, Ospedali Riuniti, Ancona, Italy
Marco Pozzi
Affiliation:
Department of Paediatric and Congenital Cardiac Surgery and Cardiology, Ospedali Riuniti, Ancona, Italy
*
Correspondence to: M. Colaneri, MD, Department of Paediatric and Congenital Cardiac Surgery and Cardiology, Ospedali Riuniti, Via Conca 71, 60126 Ancona, Italy. Tel: +39 71 596 5477; Fax: +39 71 596 5360; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We report a case of a newborn, affected by tuberous sclerosis complex, with a prenatally diagnosed giant cardiac rhabdomyoma associated with a large renal angiomyolipoma presenting as a duct-depending lesion not treatable by surgery. After receiving everolimus, a mammalian target of rapamycin inhibitor, we observed a rapid, significant, and durable reduction of both lesions without remarkable side effects.

Keywords

Cardiac rhabdomyomaangiomyolipomaeverolimustuberous sclerosis complex
Type
Brief Reports
Information
Cardiology in the Young , Volume 26 , Issue 5 , June 2016 , pp. 1025 - 1028
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Yates, JR, Maclean, C, Higgins, JN, et al. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child 2011; 96: 1020–1025.CrossRefGoogle ScholarPubMed
2. Webb, DW, Thomas, RD, Osborne, JP. Cardiac rhabdomyomas and their association with tuberous sclerosis. Arch Dis Child 1993; 68: 367–370.CrossRefGoogle ScholarPubMed
3. Bissler, JJ, Kingswood, JC. Renal angiomyolipomata. Kidney Int 2004; 66: 924–934.CrossRefGoogle ScholarPubMed
4. Krueger, DA, Care, MM, Holland, K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010; 363: 1801–1811.CrossRefGoogle ScholarPubMed
5. Wienecke, R, Fackler, I, Linsenmaier, U, Mayer, K, Licht, T, Kretzler, M. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 2006; 48: e27–e29.CrossRefGoogle ScholarPubMed
6. Morton, JM, McLean, C, Booth, SS, Snell, GI, Whitford, HM. Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment. J Heart Lung Transplant 2008; 27: 462–465.CrossRefGoogle ScholarPubMed
7. Tiberio, D, Franz, DN, Phillips, JR. Regression of a cardiac rhabdomyoma in a patient receiving everolimus. Pediatrics 2011; 127: e1335–e1337.CrossRefGoogle Scholar
8. Demir, HA, Ekici, F, Yazal Erdem, A, Emir, S, Tunc, B. Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma. Pediatrics 2012; 130: e243–e247.CrossRefGoogle ScholarPubMed
9. Dogan, V, Yesil, S, Kayali, S, et al. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus. J Trop Paediatr 2015; 61: 74–77.Google Scholar